127 related articles for article (PubMed ID: 30831552)
1. The future burden of cancer in Canada: Long-term cancer incidence projections 2013-2042.
Poirier AE; Ruan Y; Walter SD; Franco EL; Villeneuve PJ; King WD; Volesky KD; O'Sullivan DE; Friedenreich CM; Brenner DR;
Cancer Epidemiol; 2019 Apr; 59():199-207. PubMed ID: 30831552
[TBL] [Abstract][Full Text] [Related]
2. Age-standardized cancer-incidence trends in Canada, 1971-2015.
Brenner DR; Ruan Y; Shaw E; O'Sullivan D; Poirier AE; Heer E; Villeneuve PJ; Walter SD; Friedenreich CM; Smith L; De P
CMAJ; 2019 Nov; 191(46):E1262-E1273. PubMed ID: 31740536
[TBL] [Abstract][Full Text] [Related]
3. Projected estimates of cancer in Canada in 2020.
Brenner DR; Weir HK; Demers AA; Ellison LF; Louzado C; Shaw A; Turner D; Woods RR; Smith LM;
CMAJ; 2020 Mar; 192(9):E199-E205. PubMed ID: 32122974
[TBL] [Abstract][Full Text] [Related]
4. Annual report to the nation on the status of cancer, 1975-2002, featuring population-based trends in cancer treatment.
Edwards BK; Brown ML; Wingo PA; Howe HL; Ward E; Ries LA; Schrag D; Jamison PM; Jemal A; Wu XC; Friedman C; Harlan L; Warren J; Anderson RN; Pickle LW
J Natl Cancer Inst; 2005 Oct; 97(19):1407-27. PubMed ID: 16204691
[TBL] [Abstract][Full Text] [Related]
5. Projecting Cancer Incidence for 2025 in the 2 Largest Populated Cities in Vietnam.
Nguyen SM; Deppen S; Nguyen GH; Pham DX; Bui TD; Tran TV
Cancer Control; 2019; 26(1):1073274819865274. PubMed ID: 31331188
[TBL] [Abstract][Full Text] [Related]
6. Projected estimates of cancer in Canada in 2022.
Brenner DR; Poirier A; Woods RR; Ellison LF; Billette JM; Demers AA; Zhang SX; Yao C; Finley C; Fitzgerald N; Saint-Jacques N; Shack L; Turner D; Holmes E;
CMAJ; 2022 May; 194(17):E601-E607. PubMed ID: 35500919
[TBL] [Abstract][Full Text] [Related]
7. Italian cancer figures--Report 2015: The burden of rare cancers in Italy.
; Busco S; Buzzoni C; Mallone S; Trama A; Castaing M; Bella F; Amodio R; Bizzoco S; Cassetti T; Cirilli C; Cusimano R; De Angelis R; Fusco M; Gatta G; Gennaro V; Giacomin A; Giorgi Rossi P; Mangone L; Mannino S; Rossi S; Pierannunzio D; Tavilla A; Tognazzo S; Tumino R; Vicentini M; Vitale MF; Crocetti E; Dal Maso L
Epidemiol Prev; 2016; 40(1 Suppl 2):1-120. PubMed ID: 26951748
[TBL] [Abstract][Full Text] [Related]
8. Multiple sclerosis in Canada 2011 to 2031: results of a microsimulation modelling study of epidemiological and economic impacts.
Amankwah N; Marrie RA; Bancej C; Garner R; Manuel DG; Wall R; Finès P; Bernier J; Tu K; Reimer K
Health Promot Chronic Dis Prev Can; 2017 Feb; 37(2):37-48. PubMed ID: 28273039
[TBL] [Abstract][Full Text] [Related]
9. Long-term projections of cancer incidence and mortality in Canada: The OncoSim All Cancers Model.
Ruan Y; Poirier A; Yong J; Garner R; Sun Z; Than J; Brenner DR
Prev Med; 2023 Mar; 168():107425. PubMed ID: 36681276
[TBL] [Abstract][Full Text] [Related]
10. Invasive Cancer Incidence, 2004-2013, and Deaths, 2006-2015, in Nonmetropolitan and Metropolitan Counties - United States.
Henley SJ; Anderson RN; Thomas CC; Massetti GM; Peaker B; Richardson LC
MMWR Surveill Summ; 2017 Jul; 66(14):1-13. PubMed ID: 28683054
[TBL] [Abstract][Full Text] [Related]
11. Geriatric cancer trends in the Middle-East: Findings from Lebanese cancer projections until 2025.
Haddad FG; Kattan J; Kourie HR; El Rassy E; Assi T; Adib SM
J Geriatr Oncol; 2018 Mar; 9(2):120-123. PubMed ID: 28877856
[TBL] [Abstract][Full Text] [Related]
12. The current and future burden of cancer attributable to modifiable risk factors in Canada: Summary of results.
Poirier AE; Ruan Y; Volesky KD; King WD; O'Sullivan DE; Gogna P; Walter SD; Villeneuve PJ; Friedenreich CM; Brenner DR;
Prev Med; 2019 May; 122():140-147. PubMed ID: 31078167
[TBL] [Abstract][Full Text] [Related]
13. Italian cancer figures, report 2014: Prevalence and cure of cancer in Italy.
AIRTUM Working Group
Epidemiol Prev; 2014; 38(6 Suppl 1):1-122. PubMed ID: 25759295
[TBL] [Abstract][Full Text] [Related]
14. Projections of the future burden of cancer in Australia using Bayesian age-period-cohort models.
Cameron JK; Baade P
Cancer Epidemiol; 2021 Jun; 72():101935. PubMed ID: 33838461
[TBL] [Abstract][Full Text] [Related]
15. Projection of cancer incident cases for India -till 2026.
D'Souza ND; Murthy NS; Aras RY
Asian Pac J Cancer Prev; 2013; 14(7):4379-86. PubMed ID: 23992007
[TBL] [Abstract][Full Text] [Related]
16. Short-term projection of cancer incidence in Japan using an age-period interaction model with spline smoothing.
Katanoda K; Kamo K; Saika K; Matsuda T; Shibata A; Matsuda A; Nishino Y; Hattori M; Soda M; Ioka A; Sobue T; Nishimoto H
Jpn J Clin Oncol; 2014 Jan; 44(1):36-41. PubMed ID: 24218520
[TBL] [Abstract][Full Text] [Related]
17. Planning for the future: cancer incidence projections in Switzerland up to 2019.
Rapiti E; Guarnori S; Pastoors B; Miralbell R; Usel M
BMC Public Health; 2014 Feb; 14():102. PubMed ID: 24484472
[TBL] [Abstract][Full Text] [Related]
18. [The future incidence of colorectal and lung cancers: results of the calculation of different scenarios for the year 2020].
Nowossadeck E; Haberland J; Kraywinkel K
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2014 Jan; 57(1):103-10. PubMed ID: 24357179
[TBL] [Abstract][Full Text] [Related]
19. Cancer incidence in Canada: trends and projections (1983-2032).
Xie L; Semenciw R; Mery L
Health Promot Chronic Dis Prev Can; 2015; 35 Suppl 1():2-186. PubMed ID: 26011811
[TBL] [Abstract][Full Text] [Related]
20. Prostate cancer prevalence in New South Wales Australia: a population-based study.
Yu XQ; Luo Q; Smith DP; Clements MS; O'Connell DL
Cancer Epidemiol; 2015 Feb; 39(1):29-36. PubMed ID: 25530551
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
